ProfileGDS4718 / 218333_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 92% 92% 85% 92% 91% 85% 86% 92% 92% 91% 92% 92% 91% 87% 88% 92% 90% 87% 90% 85% 91% 91% 92% 92% 92% 85% 91% 90% 90% 82% 85% 85% 92% 91% 90% 90% 84% 92% 90% 86% 91% 83% 89% 89% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.5574892
GSM549102patient 115, normal, homogenized [OPG study]9.5289192
GSM549104patient 119, normal, homogenized [OPG study]8.5785885
GSM549108patient 138, normal, homogenized [OPG study]9.4407192
GSM549119patient 077, normal, homogenized [OPG study]9.4230991
GSM549133patient 032, cancer, homogenized [OPG study]8.5848285
GSM549139patient 042, cancer, homogenized [OPG study]8.6487786
GSM549099patient 107, normal, homogenized [OPG study]9.4665192
GSM549109patient 139, normal, homogenized [OPG study]9.4980892
GSM549110patient 046, normal, homogenized [OPG study]9.4577491
GSM549114patient 063, normal, homogenized [OPG study]9.8210392
GSM549122patient 082, normal, homogenized [OPG study]9.5633892
GSM549134patient 033, cancer, homogenized [OPG study]9.4271891
GSM549136patient 036, cancer, homogenized [OPG study]8.7896287
GSM549140patient 044, cancer, homogenized [OPG study]8.8744388
GSM549111patient 047, normal, homogenized [OPG study]9.6081892
GSM549113patient 057, normal, homogenized [OPG study]9.349290
GSM549132patient 031, cancer, homogenized [OPG study]8.7562487
GSM549137patient 038, cancer, homogenized [OPG study]9.2134990
GSM549142patient 047, cancer, homogenized [OPG study]8.1440285
GSM549100patient 110, normal, homogenized [OPG study]9.4363991
GSM549107patient 135, normal, homogenized [OPG study]9.5208591
GSM549115patient 068, normal, homogenized [OPG study]9.7046392
GSM549116patient 072, normal, homogenized [OPG study]9.6907892
GSM549120patient 078, normal, homogenized [OPG study]9.5159492
GSM549131patient 030, cancer, homogenized [OPG study]8.5110485
GSM549118patient 074, normal, homogenized [OPG study]9.4362591
GSM549129patient 027, cancer, homogenized [OPG study]9.0650990
GSM549123patient 088, normal, homogenized [OPG study]9.3074490
GSM549124patient 006, cancer, homogenized [OPG study]8.0064382
GSM549126patient 015, cancer, homogenized [OPG study]8.4372585
GSM549128patient 025, cancer, homogenized [OPG study]8.5146885
GSM549103patient 117, normal, homogenized [OPG study]9.4098292
GSM549117patient 073, normal, homogenized [OPG study]9.6385291
GSM549138patient 041, cancer, homogenized [OPG study]9.1296390
GSM549141patient 045, cancer, homogenized [OPG study]9.230990
GSM549130patient 028, cancer, homogenized [OPG study]8.2229784
GSM549101patient 111, normal, homogenized [OPG study]9.5156892
GSM549105patient 128, normal, homogenized [OPG study]9.214290
GSM549106patient 134, normal, homogenized [OPG study]8.6945486
GSM549112patient 048, normal, homogenized [OPG study]9.5299791
GSM549125patient 011, cancer, homogenized [OPG study]8.1894183
GSM549127patient 024, cancer, homogenized [OPG study]9.0180989
GSM549135patient 035, cancer, homogenized [OPG study]9.0533689